Commentary: tacrolimus in the treatment of chronic and refractory late-onset immune-mediated adverse effects related to silicone injections.
Department of Dermatology, University of Sourthern California, Torrance, California 90503, USA. info@drdavidmduffy.com
David M
DM
Duffy
D001672:Biocompatible Materials / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007249:Inflammation / Q000188:drug therapy*; D008297:Male; D012828:Silicones / Q000009:adverse effects*; D016559:Tacrolimus / Q000627:therapeutic use*
D001672:Biocompatible Materials; D007166:Immunosuppressive Agents; D012828:Silicones; D016559:Tacrolimus